We are live on ! Find out more
QEI

QSV Equity Investors Portfolio holdings

AUM $67.6M
1-Year Est. Return 0.29%
This Fund
S&P 500
This Quarter Est. Return
-2.29%
1 Year Est. Return
-0.29%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$95.8M
AUM Growth
-$8.1M
Cap. Flow
-$4.27M
Cap. Flow %
-4.46%
Top 10 Hldgs %
22.41%
Holding
91
New
1
Increased
13
Reduced
64
Closed
11

Top Buys

Rank Stock Value
1
CPRX
Catalyst Pharmaceutical
CPRX
+$1.31M
2
VSTS icon
Vestis
VSTS
+$585K
3
FTRE icon
Fortrea Holdings
FTRE
+$519K
4
MBUU icon
Malibu Boats
MBUU
+$483K
5
ZD icon
Ziff Davis
ZD
+$393K

Top Sells

Rank Stock Value
1
PUBM icon
PubMatic
PUBM
+$2.16M
2
SMG icon
ScottsMiracle-Gro
SMG
+$1.08M
3
SSTK icon
Shutterstock
SSTK
+$876K
4
FWRD icon
Forward Air
FWRD
+$780K
5
LH icon
Labcorp
LH
+$396K

Sector Composition

Rank Sector Weight
1 Financials 22.81%
2 Industrials 19.24%
3 Healthcare 17.81%
4 Technology 14.15%
5 Real Estate 8.8%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
HELE icon
51
Helen of Troy
HELE
$680M
$1.14M 1.18%
12,240
-76
-0.6% -$7.7K
AWR icon
52
American States Water
AWR
$3.43B
$1.1M 1.15%
15,134
-88
-0.6% -$6.35K
GMED icon
53
Globus Medical
GMED
$11.7B
$1.08M 1.12%
15,736
-91
-0.6% -$5.44K
GNRC icon
54
Generac Holdings
GNRC
$12.2B
$1.06M 1.1%
8,000
-46
-0.6% -$6.36K
FAF icon
55
First American
FAF
$7.37B
$1.05M 1.1%
19,491
-112
-0.6% -$6.22K
HBNC icon
56
Horizon Bancorp
HBNC
$1.03B
$985K 1.03%
79,595
-458
-0.6% -$5.51K
CZNC icon
57
Citizens & Northern Corp
CZNC
$454M
$921K 0.96%
51,484
-297
-0.6% -$5.19K
BAH icon
58
Booz Allen Hamilton
BAH
$9.37B
$540K 0.56%
3,507
-603
-15% -$90.4K
MOAT icon
59
VanEck Morningstar Wide Moat ETF
MOAT
$12.4B
$442K 0.46%
5,103
– –
OTIS icon
60
Otis Worldwide
OTIS
$27.7B
$356K 0.37%
3,695
-72
-2% -$6.94K
ROL icon
61
Rollins
ROL
$17.9B
$339K 0.35%
6,955
-1,110
-14% -$51.2K
CPAY icon
62
Corpay
CPAY
$26.2B
$339K 0.35%
1,275
-201
-14% -$56.9K
TYL icon
63
Tyler Technologies
TYL
$13B
$330K 0.34%
656
-323
-33% -$149K
WST icon
64
West Pharmaceutical
WST
$24.8B
$302K 0.32%
917
-144
-14% -$50.9K
GNTX icon
65
Gentex
GNTX
$5.02B
$296K 0.31%
8,766
-1,489
-15% -$51.4K
SNV
66
DELISTED
Synovus
SNV
$293K 0.31%
7,293
-1,124
-13% -$42.6K
MSA icon
67
Mine Safety
MSA
$7.45B
$283K 0.3%
1,509
-259
-15% -$48.2K
EGP icon
68
EastGroup Properties
EGP
$10.9B
$282K 0.29%
1,658
-299
-15% -$49.4K
JKHY icon
69
Jack Henry & Associates
JKHY
$11B
$277K 0.29%
1,669
-299
-15% -$49.6K
CHE icon
70
Chemed
CHE
$7.18B
$276K 0.29%
509
-75
-13% -$43K
MTCH icon
71
Match Group
MTCH
$8.43B
$274K 0.29%
9,019
+572
+7% +$18.1K
BR icon
72
Broadridge
BR
$19.8B
$270K 0.28%
1,372
-216
-14% -$42.8K
JLL icon
73
Jones Lang LaSalle
JLL
$16.4B
$269K 0.28%
1,309
-189
-13% -$36.7K
ZBRA icon
74
Zebra Technologies
ZBRA
$17.9B
$258K 0.27%
834
-136
-14% -$41.4K
CF icon
75
CF Industries
CF
$18.4B
$253K 0.26%
3,416
-507
-13% -$39.4K
1 2
3
4

Similar funds

BBW
Blue Barn Wealth Orem, Utah $68.7M AUM 16.42% 1-Year Est. Return
YCM
Yost Capital Management Houston, Texas $68.9M AUM 18.32% 1-Year Est. Return
RWA
Redmont Wealth Advisors Chicago, Illinois $66M AUM 13.09% 1-Year Est. Return
KWM
KW Wealth Management Sacramento, California $65.9M AUM
IA
Incentive AS Oslo, Norway $71.3M AUM 30.74% 1-Year Est. Return
MCL
MWG Caph Ltd Charlestown $72.4M AUM
RRCP
Rip Road Capital Partners Boston, Massachusetts $62.5M AUM 1.22% 1-Year Est. Return
BCPEMI
Bain Capital Public Equity Management II Boston, Massachusetts $62.1M AUM 25.46% 1-Year Est. Return

QSV Equity Investors's Q2 2024 Portfolio in Review

As of Q2 2024, QSV Equity Investors held 91 positions worth $95.8M, down 7.8% from $104M the previous quarter. Its ten largest holdings account for 22% of the portfolio.

QSV Equity Investors withdrew a net $4.27M in Q2 2024, closing 11 positions and reducing 64 holdings. Its most notable exit was PubMatic, an estimated $2.16M position sold in full.

By sector, the portfolio is most concentrated in Financials at 23% of assets, up from 21% a quarter earlier, followed by Industrials and Healthcare.

Against the trend, QSV Equity Investors opened a new position in Catalyst Pharmaceutical worth $1.3M.

  • QSV Equity Investors's largest Q2 2024 buy was Catalyst Pharmaceutical: 84,137 shares worth $1.3M.
  • QSV Equity Investors added most to Vestis in Q2 2024, an estimated $585K increase.
  • QSV Equity Investors's biggest Q2 2024 reduction was Simulations Plus, cutting an estimated $333K.
  • QSV Equity Investors fully exited PubMatic in Q2 2024, selling an estimated $2.16M.
  • QSV Equity Investors's ten largest holdings make up 22% of its $95.8M portfolio in Q2 2024.
  • QSV Equity Investors opened 1 new position and closed 11 in Q2 2024.
  • QSV Equity Investors's portfolio value fell 7.8% quarter-over-quarter to $95.8M.

Based on QSV Equity Investors's 13F filing for Q2 2024, filed 14 Aug 2024.